Insider Buying: Omega Healthcare Investors (NYSE:OHI) CEO Acquires 20,000 Shares of Stock

Omega Healthcare Investors, Inc. (NYSE:OHI) CEO C Taylor Pickett purchased 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 5th. The stock was bought at an average cost of $43.14 per share, for a total transaction of $862,800.00. Following the purchase, the chief executive officer directly owned 20,000 shares in the company, valued at $862,800. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Omega Healthcare Investors Price Performance

NYSE:OHI traded down $0.43 during trading hours on Thursday, reaching $42.59. 1,679,660 shares of the company were exchanged, compared to its average volume of 2,245,300. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The stock’s 50-day moving average is $41.50 and its 200-day moving average is $39.23. The firm has a market cap of $12.56 billion, a PE ratio of 26.29, a price-to-earnings-growth ratio of 1.85 and a beta of 0.69. Omega Healthcare Investors, Inc. has a twelve month low of $35.04 and a twelve month high of $43.54.

Omega Healthcare Investors (NYSE:OHI) last announced its earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.02. The business had revenue of $260.74 million for the quarter, compared to analyst estimates of $262.48 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The company’s revenue for the quarter was up 14.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. On average, sell-side analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Monday, November 3rd will be issued a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.3%. The ex-dividend date is Monday, November 3rd. Omega Healthcare Investors’s payout ratio is presently 149.72%.

Analyst Ratings Changes

A number of equities analysts have commented on OHI shares. Scotiabank increased their target price on Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a report on Thursday, August 28th. Cantor Fitzgerald started coverage on Omega Healthcare Investors in a research report on Wednesday, October 1st. They set an “overweight” rating and a $50.00 price target for the company. Truist Financial increased their price objective on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a “hold” rating in a research note on Wednesday, September 3rd. Raymond James Financial restated an “outperform” rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Finally, Royal Bank Of Canada lifted their target price on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the stock a “sector perform” rating in a research note on Thursday. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $44.29.

Institutional Trading of Omega Healthcare Investors

Several large investors have recently added to or reduced their stakes in OHI. Caitong International Asset Management Co. Ltd purchased a new position in shares of Omega Healthcare Investors during the 2nd quarter worth $26,000. Smartleaf Asset Management LLC grew its holdings in shares of Omega Healthcare Investors by 40.9% in the second quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust’s stock valued at $34,000 after purchasing an additional 268 shares during the period. CENTRAL TRUST Co increased its position in Omega Healthcare Investors by 1,654.4% during the second quarter. CENTRAL TRUST Co now owns 1,000 shares of the real estate investment trust’s stock worth $37,000 after purchasing an additional 943 shares during the last quarter. Salem Investment Counselors Inc. purchased a new position in Omega Healthcare Investors during the third quarter worth about $39,000. Finally, Bayforest Capital Ltd raised its stake in Omega Healthcare Investors by 395.2% during the second quarter. Bayforest Capital Ltd now owns 1,129 shares of the real estate investment trust’s stock worth $41,000 after purchasing an additional 901 shares during the period. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.